Article Details
Retrieved on: 2018-02-13 09:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Cascadian Therapeutics, Inc stake is new for [reportingPerson]. Date of activity: Calendar Year 2017. This shows Seth Klarman's <b>Baupost Group</b> LlcMa's positive view for Cascadian Therapeutics, Inc. For a hedge fund managing $29.88 billion in assets and having 202+ experts this is interesting position.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here